Deutsche Bank
AMLX icon

Deutsche Bank’s Amylyx Pharmaceuticals AMLX Stock Holding History

Deutsche Bank’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10M Sell
557,937
-709,848
-56% -$11M ﹤0.01% 1061
2026
Q1 		$17.6M Sell
1,267,785
-65,451
-5% -$921K 0.01% 891
2025
Q4 		$16.1M Sell
1,333,236
-32,285
-2% -$439K 0.01% 935
2025
Q3 		$18.6M Buy
1,365,521
+748,602
+121% +$7.05M 0.01% 877
2025
Q2 		$3.95M Buy
616,919
+46,062
+8% +$224K ﹤0.01% 1343
2025
Q1 		$2.02M Hold
570,857
– – ﹤0.01% 1741
2024
Q4 		$2.16M Hold
570,857
– – ﹤0.01% 1805
2024
Q3 		$1.85M Hold
570,857
– – ﹤0.01% 1798
2024
Q2 		$1.08M Sell
570,857
-185,312
-25% -$359K ﹤0.01% 1948
2024
Q1 		$2.15M Sell
756,169
-96,831
-11% -$1.27M ﹤0.01% 1628
2023
Q4 		$12.6M Buy
853,000
+828,584
+3,394% +$12.7M 0.01% 923
2023
Q3 		$447K Sell
24,416
-167,195
-87% -$3.54M ﹤0.01% 2238
2023
Q2 		$4.13M Buy
191,611
+160,291
+512% +$4.33M ﹤0.01% 1307
2023
Q1 		$919K Buy
31,320
+9,359
+43% +$325K ﹤0.01% 2155
2022
Q4 		$811K Buy
21,961
+6,977
+47% +$248K ﹤0.01% 2173
2022
Q3 		$422K Buy
14,984
+10,292
+219% +$257K ﹤0.01% 2469
2022
Q2 		$90K Sell
4,692
-657
-12% -$7.8K ﹤0.01% 3564
2022
Q1 		$69K Buy
+5,349
New +$121K ﹤0.01% 3721

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Deutsche Bank's AMLX Position: Q2 2026 in Review

Deutsche Bank reduced its Amylyx Pharmaceuticals (AMLX) stake by 56% in Q2 2026, selling an estimated $11M and leaving 557,937 shares worth $10M. The position accounts for ﹤0.01% of the portfolio, ranked #1061.

Deutsche Bank first reported a position in AMLX in Q1 2022 and has held it in 18 quarters since. The position peaked at $18.6M in Q3 2025. 207 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Deutsche Bank held 557,937 shares of Amylyx Pharmaceuticals worth $10M as of Q2 2026.
  • Deutsche Bank sold 709,848 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $11M.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1061 holding.
  • Deutsche Bank first reported a position in Amylyx Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
  • Deutsche Bank's Amylyx Pharmaceuticals position peaked at $18.6M in Q3 2025.
  • 207 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.